Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
August 6, 2018Comments Off on Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study Posted in: Guest content, Insights
This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn, John Connolly, Michael A Fischer, Aaron S Kesselheim, and Joshua J Gagne in BMJ 2018; 361 under…
The post Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study appeared first on DrugPatentWatch - Make Better Decisions.